nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—CYP2C18—Tretinoin—peripheral nervous system neoplasm	0.542	0.736	CbGbCtD
Vilazodone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0566	0.0769	CbGbCtD
Vilazodone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0526	0.0715	CbGbCtD
Vilazodone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0242	0.0328	CbGbCtD
Vilazodone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0238	0.0323	CbGbCtD
Vilazodone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0222	0.0301	CbGbCtD
Vilazodone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0151	0.0205	CbGbCtD
Vilazodone—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.000975	0.00371	CcSEcCtD
Vilazodone—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.000956	0.00364	CcSEcCtD
Vilazodone—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.000956	0.00364	CcSEcCtD
Vilazodone—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.000956	0.00364	CcSEcCtD
Vilazodone—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.000947	0.00361	CcSEcCtD
Vilazodone—Convulsion—Melphalan—peripheral nervous system neoplasm	0.000944	0.00359	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000941	0.00358	CcSEcCtD
Vilazodone—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.00094	0.00358	CcSEcCtD
Vilazodone—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.00094	0.00358	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000933	0.00355	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000933	0.00355	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Epirubicin—peripheral nervous system neoplasm	0.000927	0.00353	CcSEcCtD
Vilazodone—Hallucination—Vincristine—peripheral nervous system neoplasm	0.000921	0.00351	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000921	0.00351	CcSEcCtD
Vilazodone—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.000919	0.0035	CcSEcCtD
Vilazodone—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.000919	0.0035	CcSEcCtD
Vilazodone—Connective tissue disorder—Vincristine—peripheral nervous system neoplasm	0.00091	0.00346	CcSEcCtD
Vilazodone—Eye disorder—Alitretinoin—peripheral nervous system neoplasm	0.000898	0.00342	CcSEcCtD
Vilazodone—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00089	0.00339	CcSEcCtD
Vilazodone—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000883	0.00336	CcSEcCtD
Vilazodone—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000883	0.00336	CcSEcCtD
Vilazodone—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000882	0.00336	CcSEcCtD
Vilazodone—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.000878	0.00334	CcSEcCtD
Vilazodone—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000875	0.00333	CcSEcCtD
Vilazodone—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000875	0.00333	CcSEcCtD
Vilazodone—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.000871	0.00331	CcSEcCtD
Vilazodone—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.000871	0.00331	CcSEcCtD
Vilazodone—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000864	0.00329	CcSEcCtD
Vilazodone—Cardiac disorder—Vincristine—peripheral nervous system neoplasm	0.000859	0.00327	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Doxorubicin—peripheral nervous system neoplasm	0.000858	0.00326	CcSEcCtD
Vilazodone—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.000842	0.0032	CcSEcCtD
Vilazodone—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.000836	0.00318	CcSEcCtD
Vilazodone—Abnormal dreams—Epirubicin—peripheral nervous system neoplasm	0.000827	0.00315	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000827	0.00315	CcSEcCtD
Vilazodone—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.000824	0.00314	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000821	0.00312	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000821	0.00312	CcSEcCtD
Vilazodone—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.000815	0.0031	CcSEcCtD
Vilazodone—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000815	0.0031	CcSEcCtD
Vilazodone—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000815	0.0031	CcSEcCtD
Vilazodone—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.000812	0.00309	CcSEcCtD
Vilazodone—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.000811	0.00309	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00081	0.00308	CcSEcCtD
Vilazodone—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000809	0.00308	CcSEcCtD
Vilazodone—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000809	0.00308	CcSEcCtD
Vilazodone—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000804	0.00306	CcSEcCtD
Vilazodone—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000801	0.00305	CcSEcCtD
Vilazodone—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000801	0.00305	CcSEcCtD
Vilazodone—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000799	0.00304	CcSEcCtD
Vilazodone—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000798	0.00304	CcSEcCtD
Vilazodone—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000793	0.00302	CcSEcCtD
Vilazodone—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000793	0.00302	CcSEcCtD
Vilazodone—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000789	0.003	CcSEcCtD
Vilazodone—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000788	0.003	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000784	0.00298	CcSEcCtD
Vilazodone—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000784	0.00298	CcSEcCtD
Vilazodone—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000783	0.00298	CcSEcCtD
Vilazodone—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000783	0.00298	CcSEcCtD
Vilazodone—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000783	0.00298	CcSEcCtD
Vilazodone—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000783	0.00298	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000778	0.00296	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000778	0.00296	CcSEcCtD
Vilazodone—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000777	0.00296	CcSEcCtD
Vilazodone—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000777	0.00296	CcSEcCtD
Vilazodone—Dry eye—Epirubicin—peripheral nervous system neoplasm	0.000773	0.00294	CcSEcCtD
Vilazodone—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000773	0.00294	CcSEcCtD
Vilazodone—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000769	0.00293	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000768	0.00292	CcSEcCtD
Vilazodone—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000766	0.00292	CcSEcCtD
Vilazodone—Abnormal dreams—Doxorubicin—peripheral nervous system neoplasm	0.000766	0.00291	CcSEcCtD
Vilazodone—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.000765	0.00291	CcSEcCtD
Vilazodone—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00076	0.00289	CcSEcCtD
Vilazodone—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000748	0.00285	CcSEcCtD
Vilazodone—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000742	0.00283	CcSEcCtD
Vilazodone—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000742	0.00283	CcSEcCtD
Vilazodone—Agitation—Vincristine—peripheral nervous system neoplasm	0.000741	0.00282	CcSEcCtD
Vilazodone—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000739	0.00281	CcSEcCtD
Vilazodone—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000725	0.00276	CcSEcCtD
Vilazodone—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.000715	0.00272	CcSEcCtD
Vilazodone—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000713	0.00271	CcSEcCtD
Vilazodone—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000712	0.00271	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000707	0.00269	CcSEcCtD
Vilazodone—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000702	0.00267	CcSEcCtD
Vilazodone—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000701	0.00267	CcSEcCtD
Vilazodone—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000698	0.00266	CcSEcCtD
Vilazodone—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000696	0.00265	CcSEcCtD
Vilazodone—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000696	0.00265	CcSEcCtD
Vilazodone—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000672	0.00256	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000671	0.00255	CcSEcCtD
Vilazodone—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000669	0.00255	CcSEcCtD
Vilazodone—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000668	0.00254	CcSEcCtD
Vilazodone—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000663	0.00252	CcSEcCtD
Vilazodone—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00066	0.00251	CcSEcCtD
Vilazodone—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000651	0.00248	CcSEcCtD
Vilazodone—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000647	0.00246	CcSEcCtD
Vilazodone—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000646	0.00246	CcSEcCtD
Vilazodone—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000646	0.00246	CcSEcCtD
Vilazodone—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000645	0.00246	CcSEcCtD
Vilazodone—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00064	0.00244	CcSEcCtD
Vilazodone—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000639	0.00243	CcSEcCtD
Vilazodone—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000638	0.00243	CcSEcCtD
Vilazodone—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000636	0.00242	CcSEcCtD
Vilazodone—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000635	0.00242	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000622	0.00237	CcSEcCtD
Vilazodone—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000621	0.00236	CcSEcCtD
Vilazodone—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000617	0.00235	CcSEcCtD
Vilazodone—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000617	0.00235	CcSEcCtD
Vilazodone—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000616	0.00235	CcSEcCtD
Vilazodone—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000616	0.00235	CcSEcCtD
Vilazodone—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000613	0.00233	CcSEcCtD
Vilazodone—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.00061	0.00232	CcSEcCtD
Vilazodone—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000608	0.00232	CcSEcCtD
Vilazodone—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000607	0.00231	CcSEcCtD
Vilazodone—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000607	0.00231	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000603	0.00229	CcSEcCtD
Vilazodone—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000601	0.00229	CcSEcCtD
Vilazodone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.0006	0.00229	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000599	0.00228	CcSEcCtD
Vilazodone—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000598	0.00228	CcSEcCtD
Vilazodone—Migraine—Epirubicin—peripheral nervous system neoplasm	0.000598	0.00228	CcSEcCtD
Vilazodone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000596	0.00227	CcSEcCtD
Vilazodone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000596	0.00227	CcSEcCtD
Vilazodone—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000595	0.00226	CcSEcCtD
Vilazodone—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000593	0.00226	CcSEcCtD
Vilazodone—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000591	0.00225	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000589	0.00224	CcSEcCtD
Vilazodone—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000589	0.00224	CcSEcCtD
Vilazodone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000577	0.0022	CcSEcCtD
Vilazodone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000573	0.00218	CcSEcCtD
Vilazodone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000573	0.00218	CcSEcCtD
Vilazodone—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000572	0.00218	CcSEcCtD
Vilazodone—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00057	0.00217	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000568	0.00216	CcSEcCtD
Vilazodone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000567	0.00216	CcSEcCtD
Vilazodone—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000566	0.00215	CcSEcCtD
Vilazodone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000565	0.00215	CcSEcCtD
Vilazodone—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000565	0.00215	CcSEcCtD
Vilazodone—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000565	0.00215	CcSEcCtD
Vilazodone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000563	0.00214	CcSEcCtD
Vilazodone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000562	0.00214	CcSEcCtD
Vilazodone—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000553	0.00211	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000552	0.0021	CcSEcCtD
Vilazodone—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000549	0.00209	CcSEcCtD
Vilazodone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000539	0.00205	CcSEcCtD
Vilazodone—Aripiprazole—ABCB1—peripheral nervous system neoplasm	0.000539	0.501	CrCbGaD
Vilazodone—Trazodone—ABCB1—peripheral nervous system neoplasm	0.000537	0.499	CrCbGaD
Vilazodone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000535	0.00204	CcSEcCtD
Vilazodone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000535	0.00204	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00053	0.00202	CcSEcCtD
Vilazodone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000528	0.00201	CcSEcCtD
Vilazodone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000528	0.00201	CcSEcCtD
Vilazodone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000522	0.00199	CcSEcCtD
Vilazodone—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000518	0.00197	CcSEcCtD
Vilazodone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000515	0.00196	CcSEcCtD
Vilazodone—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.00193	CcSEcCtD
Vilazodone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000506	0.00192	CcSEcCtD
Vilazodone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000504	0.00192	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000502	0.00191	CcSEcCtD
Vilazodone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00049	0.00186	CcSEcCtD
Vilazodone—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000485	0.00185	CcSEcCtD
Vilazodone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000479	0.00182	CcSEcCtD
Vilazodone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000478	0.00182	CcSEcCtD
Vilazodone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000474	0.0018	CcSEcCtD
Vilazodone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000472	0.0018	CcSEcCtD
Vilazodone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000468	0.00178	CcSEcCtD
Vilazodone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000467	0.00178	CcSEcCtD
Vilazodone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000463	0.00176	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00046	0.00175	CcSEcCtD
Vilazodone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000459	0.00175	CcSEcCtD
Vilazodone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000451	0.00172	CcSEcCtD
Vilazodone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00045	0.00171	CcSEcCtD
Vilazodone—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.00171	CcSEcCtD
Vilazodone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000439	0.00167	CcSEcCtD
Vilazodone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000437	0.00166	CcSEcCtD
Vilazodone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000435	0.00166	CcSEcCtD
Vilazodone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000434	0.00165	CcSEcCtD
Vilazodone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000418	0.00159	CcSEcCtD
Vilazodone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000417	0.00159	CcSEcCtD
Vilazodone—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000413	0.00157	CcSEcCtD
Vilazodone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000405	0.00154	CcSEcCtD
Vilazodone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000398	0.00151	CcSEcCtD
Vilazodone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000393	0.0015	CcSEcCtD
Vilazodone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000391	0.00149	CcSEcCtD
Vilazodone—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00039	0.00149	CcSEcCtD
Vilazodone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000382	0.00146	CcSEcCtD
Vilazodone—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.00146	CcSEcCtD
Vilazodone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00037	0.00141	CcSEcCtD
Vilazodone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000368	0.0014	CcSEcCtD
Vilazodone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000366	0.00139	CcSEcCtD
Vilazodone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000365	0.00139	CcSEcCtD
Vilazodone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.00138	CcSEcCtD
Vilazodone—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.00137	CcSEcCtD
Vilazodone—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000361	0.00137	CcSEcCtD
Vilazodone—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000358	0.00136	CcSEcCtD
Vilazodone—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000355	0.00135	CcSEcCtD
Vilazodone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000352	0.00134	CcSEcCtD
Vilazodone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000345	0.00132	CcSEcCtD
Vilazodone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000345	0.00131	CcSEcCtD
Vilazodone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.0013	CcSEcCtD
Vilazodone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000339	0.00129	CcSEcCtD
Vilazodone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.00129	CcSEcCtD
Vilazodone—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000336	0.00128	CcSEcCtD
Vilazodone—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.00127	CcSEcCtD
Vilazodone—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.00126	CcSEcCtD
Vilazodone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.00125	CcSEcCtD
Vilazodone—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000323	0.00123	CcSEcCtD
Vilazodone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.00121	CcSEcCtD
Vilazodone—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000317	0.00121	CcSEcCtD
Vilazodone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000316	0.0012	CcSEcCtD
Vilazodone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000312	0.00119	CcSEcCtD
Vilazodone—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.00118	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000309	0.00118	CcSEcCtD
Vilazodone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000305	0.00116	CcSEcCtD
Vilazodone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.00114	CcSEcCtD
Vilazodone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.00112	CcSEcCtD
Vilazodone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000293	0.00111	CcSEcCtD
Vilazodone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00029	0.0011	CcSEcCtD
Vilazodone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000289	0.0011	CcSEcCtD
Vilazodone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.0011	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.00109	CcSEcCtD
Vilazodone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.00107	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000272	0.00104	CcSEcCtD
Vilazodone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.00103	CcSEcCtD
Vilazodone—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00027	0.00103	CcSEcCtD
Vilazodone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.00102	CcSEcCtD
Vilazodone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000268	0.00102	CcSEcCtD
Vilazodone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.00102	CcSEcCtD
Vilazodone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000266	0.00101	CcSEcCtD
Vilazodone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000263	0.001	CcSEcCtD
Vilazodone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000988	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000982	CcSEcCtD
Vilazodone—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000258	0.00098	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000958	CcSEcCtD
Vilazodone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000951	CcSEcCtD
Vilazodone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000945	CcSEcCtD
Vilazodone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000937	CcSEcCtD
Vilazodone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000935	CcSEcCtD
Vilazodone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000926	CcSEcCtD
Vilazodone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000914	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000908	CcSEcCtD
Vilazodone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000907	CcSEcCtD
Vilazodone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000867	CcSEcCtD
Vilazodone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000816	CcSEcCtD
Vilazodone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000778	CcSEcCtD
Vilazodone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000755	CcSEcCtD
Vilazodone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000752	CcSEcCtD
Vilazodone—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000723	CcSEcCtD
Vilazodone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.00072	CcSEcCtD
Vilazodone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000696	CcSEcCtD
Vilazodone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000675	CcSEcCtD
Vilazodone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000669	CcSEcCtD
Vilazodone—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000625	CcSEcCtD
